本页面由Tiger Trade Technology Pte. Ltd.提供服务

Mirum Pharmaceuticals, Inc.

79.62
-6.4400-7.48%
盘后:79.910.2900+0.36%19:30 EDT
成交量:76.26万
成交额:6,203.15万
市值:51.70亿
市盈率:-5.65
高:87.00
开:86.06
低:79.51
收:86.06
52周最高:130.00
52周最低:63.23
股本:6,493.22万
流通股本:5,641.51万
量比:0.74
换手率:1.35%
股息:- -
股息率:- -
每股收益(TTM):-14.0800
每股收益(LYR):-0.4700
净资产收益率:-702.97%
总资产收益率:-6.79%
市净率:-496.06
市盈率(LYR):-169.40

数据加载中...

2020/05/07

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/05/07

员工持股计划

Securities to be offered to employees in employee benefit plans
2020/04/29

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/03/12

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/12

重要事件披露

Current report, items 2.02 and 9.01
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/17

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/01/14

重要事件披露

Current report, items 5.02, 8.01, and 9.01
2020/01/06

SEC问询函

[Cover]Correspondence
2020/01/06

SEC问询函

[Cover]Correspondence
2020/01/06

招股说明书

General form for registration of securities under the Securities Act of 1933
2019/12/27

重要事件披露

Current report, items 5.02 and 9.01
2019/12/16

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/11/06

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/11/06

重要事件披露

Current report, items 2.02 and 9.01
2019/09/10

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/08/28

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/08/28

员工持股计划

Securities to be offered to employees in employee benefit plans
2019/08/28

重要事件披露

Current report, items 2.02 and 9.01